{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:16:13Z","timestamp":1790471773424,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11882-019-0887-x","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T07:02:40Z","timestamp":1574838160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations"],"prefix":"10.1007","volume":"19","author":[{"given":"Paneez","family":"Khoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"issue":"1","key":"887_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.2011.01028.x","volume":"242","author":"SR Boden","year":"2011","unstructured":"Boden SR, Wesley BA. Anaphylaxis: a history with emphasis on food allergy. Immunol Rev. 2011;242(1):247\u201357.","journal-title":"Immunol Rev"},{"key":"887_CR2","doi-asserted-by":"crossref","unstructured":"Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391\u20137.","DOI":"10.1016\/j.jaci.2005.12.1303"},{"issue":"10","key":"887_CR3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","volume":"359","author":"BL Zuraw","year":"2008","unstructured":"Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027\u201336.","journal-title":"N Engl J Med"},{"issue":"2","key":"887_CR4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188\u201395.","journal-title":"Blood."},{"issue":"5","key":"887_CR5","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaip.2018.01.006","volume":"6","author":"S Dua","year":"2018","unstructured":"\u2022 Dua S, Dowey J, Foley L, Islam S, King Y, Ewan P, et al. Diagnostic value of tryptase in food allergic reactions: a prospective study of 160 adult peanut challenges. J Allergy Clin Immunol Pract. 2018;6(5):1692\u20138 e1. Prospective and systematic evaluation of serum tryptase in controlled food challenge reactions.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"887_CR6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4168\/aair.2014.6.4.304","volume":"6","author":"P Wongkaewpothong","year":"2014","unstructured":"Wongkaewpothong P, Pacharn P, Sripramong C, Boonchoo S, Piboonpocanun S, Visitsunthorn N, et al. The utility of serum tryptase in the diagnosis of food-induced anaphylaxis. Allergy, Asthma Immunol Res. 2014;6(4):304\u20139.","journal-title":"Allergy, Asthma Immunol Res"},{"issue":"4","key":"887_CR7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","volume":"112","author":"DD Metcalfe","year":"2008","unstructured":"Metcalfe DD. Mast cells and mastocytosis. Blood. 2008;112(4):946\u201356.","journal-title":"Blood."},{"key":"887_CR8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0076-6879(94)44008-5","volume":"244","author":"LB Schwartz","year":"1994","unstructured":"Schwartz LB. Tryptase: a mast cell serine protease. Methods Enzymol. 1994;244:88\u2013100.","journal-title":"Methods Enzymol"},{"issue":"7","key":"887_CR9","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.138.7.2184","volume":"138","author":"MC Castells","year":"1987","unstructured":"Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987;138(7):2184\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"887_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1067\/mai.2002.121454","volume":"109","author":"B Foster","year":"2002","unstructured":"Foster B, Schwartz LB, Devouassoux G, Metcalfe DD, Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol. 2002;109(2):287\u201393.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"887_CR11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2362.2009.02184.x","volume":"39","author":"WR Sperr","year":"2009","unstructured":"Sperr WR, El-Samahi A, Kundi M, Girschikofsky M, Winkler S, Lutz D, et al. Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology. Eur J Clin Investig. 2009;39(10):914\u201323.","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"887_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","volume":"157","author":"P Valent","year":"2012","unstructured":"Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157(3):215\u201325.","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"887_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0091-6749(06)80017-5","volume":"90","author":"PW van der Linden","year":"1992","unstructured":"van der Linden PW, Hack CE, Poortman J, Vivie-Kipp YC, Struyvenberg A, van der Zwan JK. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol. 1992;90(1):110\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"887_CR14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2004.02.032","volume":"113","author":"S Jogie-Brahim","year":"2004","unstructured":"Jogie-Brahim S, Min HK, Fukuoka Y, Xia HZ, Schwartz LB. Expression of alpha-tryptase and beta-tryptase by human basophils. J Allergy Clin Immunol. 2004;113(6):1086\u201392.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"887_CR15","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.138.8.2611","volume":"138","author":"LB Schwartz","year":"1987","unstructured":"Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138(8):2611\u20135.","journal-title":"J Immunol"},{"issue":"4","key":"887_CR16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI118523","volume":"97","author":"K Sakai","year":"1996","unstructured":"Sakai K, Ren S, Schwartz LB. A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest. 1996;97(4):988\u201395.","journal-title":"J Clin Invest"},{"issue":"11","key":"887_CR17","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.4049\/jimmunol.170.11.5667","volume":"170","author":"LB Schwartz","year":"2003","unstructured":"Schwartz LB, Min HK, Ren S, Xia HZ, Hu J, Zhao W, et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, mono-Mac-6 cells, and human skin-derived mast cells. J Immunol. 2003;170(11):5667\u201373.","journal-title":"J Immunol"},{"issue":"6","key":"887_CR18","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2006.02.026","volume":"117","author":"GH Caughey","year":"2006","unstructured":"Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol. 2006;117(6):1411\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"887_CR19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2009.07.026","volume":"124","author":"NN Trivedi","year":"2009","unstructured":"Trivedi NN, Tamraz B, Chu C, Kwok PY, Caughey GH. Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. J Allergy Clin Immunol. 2009;124(5):1099\u2013105 e1-4.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"887_CR20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa070030","volume":"358","author":"P Vadas","year":"2008","unstructured":"Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008;358(1):28\u201335.","journal-title":"N Engl J Med"},{"issue":"5","key":"887_CR21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1172\/JCI114051","volume":"83","author":"LB Schwartz","year":"1989","unstructured":"Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest. 1989;83(5):1551\u20135.","journal-title":"J Clin Invest"},{"issue":"6","key":"887_CR22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1067\/mai.2001.115631","volume":"107","author":"MT Krishna","year":"2001","unstructured":"Krishna MT, Chauhan A, Little L, Sampson K, Hawksworth R, Mant T, et al. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol. 2001;107(6):1039\u201345.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"887_CR23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2036.2002.01194.x","volume":"16","author":"WJ Tremaine","year":"2002","unstructured":"Tremaine WJ, Brzezinski A, Katz JA, Wolf DC, Fleming TJ, Mordenti J, et al. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Pharmacol Ther. 2002;16(3):407\u201313.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"887_CR24","first-page":"861","volume":"74","author":"T Imamura","year":"1996","unstructured":"Imamura T, Dubin A, Moore W, Tanaka R, Travis J. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Investig. 1996;74(5):861\u201370.","journal-title":"Lab Investig"},{"issue":"4","key":"887_CR25","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.4049\/jimmunol.130.4.1891","volume":"130","author":"LB Schwartz","year":"1983","unstructured":"Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol. 1983;130(4):1891\u20135.","journal-title":"J Immunol"},{"issue":"28","key":"887_CR26","doi-asserted-by":"crossref","first-page":"19670","DOI":"10.1074\/jbc.274.28.19670","volume":"274","author":"C Huang","year":"1999","unstructured":"Huang C, Li L, Krilis SA, Chanasyk K, Tang Y, Li Z, et al. Human tryptases alpha and beta\/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J Biol Chem. 1999;274(28):19670\u20136.","journal-title":"J Biol Chem"},{"issue":"10","key":"887_CR27","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1084\/jem.20190701","volume":"216","author":"Quang T. Le","year":"2019","unstructured":"\u2022\u2022 Le QT, Lyons JJ, Naranjo AN, Olivera A, Lazarus RA, Metcalfe DD, et al. Impact of naturally forming human alpha\/beta-tryptase heterotetramers in the pathogenesis of hereditary alpha-tryptasemia. J Exp Med. 2019;216(10):2348-2361. https:\/\/doi.org\/10.1084\/jem.20190701. First demonstration of heterotetrameric human tryptases with unique physiochemical properties.","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"887_CR28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa1500611","volume":"374","author":"SE Boyden","year":"2016","unstructured":"Boyden SE, Desai A, Cruse G, Young ML, Bolan HC, Scott LM, et al. Vibratory urticaria associated with a missense variant in ADGRE2. N Engl J Med. 2016;374(7):656\u201363.","journal-title":"N Engl J Med"},{"issue":"6","key":"887_CR29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","volume":"42","author":"C Fellinger","year":"2014","unstructured":"Fellinger C, Hemmer W, Wohrl S, Sesztak-Greinecker G, Jarisch R, Wantke F. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase. Allergol Immunopathol (Madr). 2014;42(6):544\u201352.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"5","key":"887_CR30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1515\/CCLM.2010.124","volume":"48","author":"A Gonzalez-Quintela","year":"2010","unstructured":"Gonzalez-Quintela A, Vizcaino L, Gude F, Rey J, Meijide L, Fernandez-Merino C, et al. Factors influencing serum total tryptase concentrations in a general adult population. Clin Chem Lab Med. 2010;48(5):701\u20136.","journal-title":"Clin Chem Lab Med"},{"key":"887_CR31","unstructured":"\u2022 Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet. 2016;48(12):1564\u20139. Identified the structural genetic variants that cause hereditary alpha-tryptasemia."},{"issue":"4","key":"887_CR32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","volume":"38","author":"V Sabato","year":"2018","unstructured":"Sabato V, Chovanec J, Faber M, Milner JD, Ebo D, Lyons JJ. First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease. J Clin Immunol. 2018;38(4):457\u20139.","journal-title":"J Clin Immunol"},{"issue":"3","key":"887_CR33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","volume":"38","author":"JJ Lyons","year":"2018","unstructured":"Lyons JJ. Hereditary alpha tryptasemia: genotyping and associated clinical features. Immunol Allergy Clin N Am. 2018;38(3):483\u201395.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"887_CR34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","volume":"133","author":"JJ Lyons","year":"2014","unstructured":"Lyons JJ, Sun G, Stone KD, Nelson C, Wisch L, O'Brien M, et al. Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities. J Allergy Clin Immunol. 2014;133(5):1471\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"887_CR35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2017.06.007","volume":"140","author":"C Akin","year":"2017","unstructured":"Akin C. Mast cell activation syndromes. J Allergy Clin Immunol. 2017;140(2):349\u201355.","journal-title":"J Allergy Clin Immunol"},{"issue":"45","key":"887_CR36","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.3748\/wjg.14.7005","volume":"14","author":"JK Lee","year":"2008","unstructured":"Lee JK, Whittaker SJ, Enns RA, Zetler P. Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol. 2008;14(45):7005\u20138.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"887_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C. Mast cells, mastocytosis, and related disorders. N Engl J Med. 2015;373(2):163\u201372.","journal-title":"N Engl J Med"},{"issue":"4","key":"887_CR38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","volume":"10","author":"P Bonadonna","year":"2010","unstructured":"Bonadonna P, Zanotti R, Muller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):347\u201353.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"887_CR39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","volume":"63","author":"K Brockow","year":"2008","unstructured":"Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63(2):226\u201332.","journal-title":"Allergy."},{"issue":"1","key":"887_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","volume":"44","author":"T Gulen","year":"2014","unstructured":"Gulen T, Hagglund H, Dahlen B, Nilsson G. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Clin Exp Allergy. 2014;44(1):121\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"887_CR41","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jaip.2017.08.039","volume":"6","author":"E Schussler","year":"2018","unstructured":"Schussler E, Yang A, Lyons JJ, Milner JD, Wang J. Persistent tryptase elevation in a patient with Gaucher disease. J Allergy Clin Immunol Pract. 2018;6(2):697\u20139.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"887_CR42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jaci.2019.05.007","volume":"144","author":"A Desai","year":"2019","unstructured":"Desai A, Sowerwine K, Liu Y, Lawrence MG, Chovanec J, Hsu AP, et al. GATA-2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in human subjects. J Allergy Clin Immunol. 2019;144(2):613\u20137 e14.","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"887_CR43","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","volume":"316","author":"LB Schwartz","year":"1987","unstructured":"Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med. 1987;316(26):1622\u20136.","journal-title":"N Engl J Med"},{"issue":"11","key":"887_CR44","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","volume":"129","author":"P Valent","year":"2017","unstructured":"Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129(11):1420\u20137.","journal-title":"Blood."},{"issue":"5","key":"887_CR45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/adc.86.5.315","volume":"86","author":"MC Carter","year":"2002","unstructured":"Carter MC, Metcalfe DD. Paediatric mastocytosis. Arch Dis Child. 2002;86(5):315\u20139.","journal-title":"Arch Dis Child"},{"issue":"3","key":"887_CR46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0889-8588(05)70295-1","volume":"14","author":"NA Soter","year":"2000","unstructured":"Soter NA. Mastocytosis and the skin. Hematol Oncol Clin North Am. 2000;14(3):537\u201355 vi.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"887_CR47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","volume":"133","author":"RA Wood","year":"2014","unstructured":"Wood RA, Camargo CA Jr, Lieberman P, Sampson HA, Schwartz LB, Zitt M, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(2):461\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"887_CR48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/jrsm.2008.070306","volume":"101","author":"A Sheikh","year":"2008","unstructured":"Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med. 2008;101(3):139\u201343.","journal-title":"J R Soc Med"},{"issue":"5","key":"887_CR49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-015-0525-1","volume":"15","author":"A Matito","year":"2015","unstructured":"Matito A, Carter M. Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis? Curr Allergy Asthma Rep. 2015;15(5):22.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"887_CR50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","volume":"128","author":"WR Sperr","year":"2002","unstructured":"Sperr WR, Jordan JH, Fiegl M, Escribano L, Bellas C, Dirnhofer S, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128(2):136\u201341.","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"887_CR51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/leu.2013.227","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A, Chen D, Abdelrahman RA, Reichard KK, Zblewski D, Wood AJ, et al. Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis. Leukemia. 2013;27(10):2091\u20134.","journal-title":"Leukemia."},{"issue":"12","key":"887_CR52","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","volume":"101","author":"AD Klion","year":"2003","unstructured":"Klion AD, Noel P, Akin C, Law MA, Gilliland DG, Cools J, et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood. 2003;101(12):4660\u20136.","journal-title":"Blood."},{"issue":"2","key":"887_CR53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.seminhematol.2012.01.007","volume":"49","author":"J Gotlib","year":"2012","unstructured":"Gotlib J, Akin C. Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders. Semin Hematol. 2012;49(2):128\u201337.","journal-title":"Semin Hematol"},{"issue":"3","key":"887_CR54","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","volume":"120","author":"I Maric","year":"2007","unstructured":"Maric I, Robyn J, Metcalfe DD, Fay MP, Carter M, Wilson T, et al. KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol. 2007;120(3):680\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"887_CR55","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","volume":"124","author":"PU Ogbogu","year":"2009","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol. 2009;124(6):1319\u201325 e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"887_CR56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/17474086.2014.955008","volume":"7","author":"P Valent","year":"2014","unstructured":"Valent P, Sperr WR, Sotlar K, Reiter A, Akin C, Gotlib J, et al. The serum tryptase test: an emerging robust biomarker in clinical hematology. Expert Rev Hematol. 2014;7(5):683\u201390.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"887_CR57","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10620-018-5298-7","volume":"64","author":"GR Kutty","year":"2019","unstructured":"Kutty GR, Downs-Kelly E, Crispin HT, Peterson KA. Elevated tryptase in EoE is an independent phenomenon associated with extra-esophageal symptoms. Dig Dis Sci. 2019;64(1):152\u20137.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"887_CR58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2016-09-737817","volume":"129","author":"Chi A. Ma","year":"2017","unstructured":"\u2022 Ma CA, Xi L, Cauff B, DeZure A, Freeman AF, Hambleton S, et al. Somatic STAT5b gain-of-function mutations in early onset nonclonal eosinophilia, urticaria, dermatitis, and diarrhea. Blood. 2017;129(5):650\u20133. Demonstrates concomitant hypereosinophilia and mast cell activation caused by clonal myeloid disease.","journal-title":"Blood"},{"issue":"9","key":"887_CR59","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","volume":"124","author":"MJ Kiel","year":"2014","unstructured":"Kiel MJ, Velusamy T, Rolland D, Sahasrabuddhe AA, Chung F, Bailey NG, et al. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood. 2014;124(9):1460\u201372.","journal-title":"Blood."},{"issue":"7","key":"887_CR60","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","volume":"98","author":"WR Sperr","year":"2001","unstructured":"Sperr WR, Jordan JH, Baghestanian M, Kiener HP, Samorapoompichit P, Semper H, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood. 2001;98(7):2200\u20139.","journal-title":"Blood."},{"issue":"3","key":"887_CR61","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2006.06310.x","volume":"135","author":"H Ichikawa","year":"2006","unstructured":"Ichikawa H, Tanabe K, Mizushima H, Hayashi Y, Mizutani S, Ishii E, et al. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia. Br J Haematol. 2006;135(3):336\u201347.","journal-title":"Br J Haematol"},{"issue":"5","key":"887_CR62","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/10428190500513652","volume":"47","author":"K Sonneck","year":"2006","unstructured":"Sonneck K, Florian S, Bohm A, Krauth MT, Kondo R, Hauswirth AW, et al. Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemia. Leuk Lymphoma. 2006;47(5):897\u2013906.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"887_CR63","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1200\/JCO.2009.24.4426","volume":"28","author":"S Bresolin","year":"2010","unstructured":"Bresolin S, Zecca M, Flotho C, Trentin L, Zangrando A, Sainati L, et al. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. J Clin Oncol. 2010;28(11):1919\u201327.","journal-title":"J Clin Oncol"},{"issue":"8","key":"887_CR64","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.leu.2404270","volume":"20","author":"O Frank","year":"2006","unstructured":"Frank O, Brors B, Fabarius A, Li L, Haak M, Merk S, et al. Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia. 2006;20(8):1400\u20137.","journal-title":"Leukemia."},{"issue":"9","key":"887_CR65","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2362.2010.02334.x","volume":"40","author":"KS Saini","year":"2010","unstructured":"Saini KS, Patnaik MM, Tefferi A. Polycythemia vera-associated pruritus and its management. Eur J Clin Investig. 2010;40(9):828\u201334.","journal-title":"Eur J Clin Investig"},{"issue":"1","key":"887_CR66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.1987.tb05787.x","volume":"116","author":"N Jackson","year":"1987","unstructured":"Jackson N, Burt D, Crocker J, Boughton B. Skin mast cells in polycythaemia vera: relationship to the pathogenesis and treatment of pruritus. Br J Dermatol. 1987;116(1):21\u20139.","journal-title":"Br J Dermatol"},{"issue":"23","key":"887_CR67","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1182\/blood-2008-09-179416","volume":"113","author":"T Ishii","year":"2009","unstructured":"Ishii T, Wang J, Zhang W, Mascarenhas J, Hoffman R, Dai Y, et al. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders. Blood. 2009;113(23):5942\u201350.","journal-title":"Blood."},{"issue":"2","key":"887_CR68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1301946","volume":"193","author":"X Jin","year":"2014","unstructured":"Jin X, Zhao W, Kirabo A, Park SO, Ho WT, Sayeski PP, et al. Elevated levels of mast cells are involved in pruritus associated with polycythemia vera in JAK2V617F transgenic mice. J Immunol. 2014;193(2):477\u201384.","journal-title":"J Immunol"},{"issue":"9","key":"887_CR69","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","volume":"33","author":"G Haeberli","year":"2003","unstructured":"Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33(9):1216\u201320.","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"887_CR70","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","volume":"124","author":"F Rueff","year":"2009","unstructured":"Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124(5):1047\u201354.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"887_CR71","first-page":"65","volume":"17","author":"I Kucharewicz","year":"2007","unstructured":"Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M. Basal serum tryptase level correlates with severity of hymenoptera sting and age. J Investig Allergol Clin Immunol. 2007;17(2):65\u20139.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"887_CR72","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000497235","volume":"179","author":"Vinicius Aniceto","year":"2019","unstructured":"Aniceto V, Dias MM, Melo JML, Trevisan-Neto O, Aragon DC, Maia LSM, et al. Serum baseline tryptase level as a marker for the severity of anaphylaxis. Int Arch Allergy Immunol. 2019;179(3):201-208. https:\/\/doi.org\/10.1159\/000497235.","journal-title":"International Archives of Allergy and Immunology"},{"issue":"2","key":"887_CR73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/all.12317","volume":"69","author":"UM Sahiner","year":"2014","unstructured":"Sahiner UM, Yavuz ST, Buyuktiryaki B, Cavkaytar O, Yilmaz EA, Tuncer A, et al. Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. Allergy. 2014;69(2):265\u20138.","journal-title":"Allergy."},{"issue":"7","key":"887_CR74","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"C Akin","year":"2007","unstructured":"Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \"idiopathic\" anaphylaxis. Blood. 2007;110(7):2331\u20133.","journal-title":"Blood."},{"issue":"1","key":"887_CR75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaci.2017.05.036","volume":"141","author":"MC Carter","year":"2018","unstructured":"Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, et al. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. J Allergy Clin Immunol. 2018;141(1):180\u20138 e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"887_CR76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ajd.12146","volume":"56","author":"E Aberer","year":"2015","unstructured":"Aberer E, Savic S, Bretterklieber A, Reiter H, Berghold A, Aberer W. Disease spectrum in patients with elevated serum tryptase levels. Australas J Dermatol. 2015;56(1):7\u201313.","journal-title":"Australas J Dermatol"},{"issue":"2","key":"887_CR77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin N Am. 2014;34(2):283\u201395.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"12","key":"887_CR78","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1365-2222.2010.03582.x","volume":"40","author":"M Ferrer","year":"2010","unstructured":"Ferrer M, Nunez-Cordoba JM, Luquin E, Grattan CE, De la Borbolla JM, Sanz ML, et al. Serum total tryptase levels are increased in patients with active chronic urticaria. Clin Exp Allergy. 2010;40(12):1760\u20136.","journal-title":"Clin Exp Allergy"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-019-0887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-019-0887-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-019-0887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:03:02Z","timestamp":1695466982000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-019-0887-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s11882-019-0887-x","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"27 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"55"}}